Form 4: Health Catalyst CEO Sells Shares to Cover Tax Obligations

Health Catalyst CEO Daniel D. Burton sold 30,897 shares of common stock to cover tax obligations related to the vesting of restricted stock units.

Summary

• Health Catalyst CEO Daniel D. Burton sold 30,897 shares of common stock on December 1, 2024.
• The sale was executed at a price of $8.9732 per share.
• This transaction was not a discretionary trade but rather a 'sell to cover' transaction mandated by the company's equity incentive plans to satisfy tax withholding obligations.
• Following the transaction, Mr. Burton directly owns 1,128,137 shares of Health Catalyst common stock.

Sentiment

Score: 5

Explanation: The document describes a routine transaction related to tax obligations, which is neither positive nor negative for the company's performance.

Industry Context

This is a routine transaction related to executive compensation and tax obligations, common in publicly traded companies.

Comparison to Industry Standards

• Executive stock sales to cover tax obligations are a standard practice across publicly listed companies.
• Many companies use 'sell to cover' mechanisms as part of their equity compensation plans.
• The number of shares sold is relatively small compared to the total holdings of the CEO, which is not unusual.

Stakeholder Impact

• The transaction has a minimal impact on shareholders as it is a routine sale to cover tax obligations.

Key Dates

Keywords

Health Catalyst, HCAT, Daniel D. Burton, stock sale, insider trading, tax obligations, restricted stock units, sell to cover